BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Semmo N, Weber T, Idle JR, Beyoğlu D. Metabolomics reveals that aldose reductase activity due to AKR1B10 is upregulated in hepatitis C virus infection. J Viral Hepat 2015;22:617-24. [PMID: 25487531 DOI: 10.1111/jvh.12376] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Simillion C, Semmo N, Idle JR, Beyoğlu D. Robust Regression Analysis of GCMS Data Reveals Differential Rewiring of Metabolic Networks in Hepatitis B and C Patients. Metabolites 2017;7:E51. [PMID: 28991180 DOI: 10.3390/metabo7040051] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
2 Nishinaka T, Miura T, Shimizu K, Terada T. Identification and characterization of functional antioxidant response elements in the promoter of the aldo-keto reductase AKR1B10 gene. Chem Biol Interact 2017;276:160-6. [PMID: 28219640 DOI: 10.1016/j.cbi.2017.02.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
3 D'Espessailles A, Campos V, Juretić N, Tapia GS, Pettinelli P. Hepatic retinaldehyde dehydrogenases are modulated by tocopherol supplementation in mice with hepatic steatosis. Nutrition 2021;94:111539. [PMID: 34974285 DOI: 10.1016/j.nut.2021.111539] [Reference Citation Analysis]
4 Keogh A, Şenkardeş S, Idle JR, Küçükgüzel ŞG, Beyoğlu D. A Novel Anti-Hepatitis C Virus and Antiproliferative Agent Alters Metabolic Networks in HepG2 and Hep3B Cells. Metabolites 2017;7:E23. [PMID: 28574427 DOI: 10.3390/metabo7020023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
5 Liu LL, Lin Y, Chen W, Tong ML, Luo X, Lin LR, Zhang HL, Yan JH, Niu JJ, Yang TC. Metabolite Profiles of the Cerebrospinal Fluid in Neurosyphilis Patients Determined by Untargeted Metabolomics Analysis. Front Neurosci 2019;13:150. [PMID: 30863278 DOI: 10.3389/fnins.2019.00150] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Idle JR, Seipel K, Bacher U, Pabst T, Beyoğlu D. (2R,3S)-Dihydroxybutanoic Acid Synthesis as a Novel Metabolic Function of Mutant Isocitrate Dehydrogenase 1 and 2 in Acute Myeloid Leukemia. Cancers (Basel) 2020;12:E2842. [PMID: 33019704 DOI: 10.3390/cancers12102842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 DiStefano JK, Davis B. Diagnostic and Prognostic Potential of AKR1B10 in Human Hepatocellular Carcinoma. Cancers (Basel). 2019;11. [PMID: 30959792 DOI: 10.3390/cancers11040486] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
8 Beyoğlu D, Idle JR. Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy. Metabolites 2020;10:E50. [PMID: 32012846 DOI: 10.3390/metabo10020050] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
9 Beyoğlu D, Zhou Y, Chen C, Idle JR. Mass isotopomer-guided decluttering of metabolomic data to visualize endogenous biomarkers of drug toxicity. Biochem Pharmacol 2018;156:491-500. [PMID: 30243960 DOI: 10.1016/j.bcp.2018.09.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
10 Beyoğlu D, Idle JR. Metabolic Rewiring and the Characterization of Oncometabolites. Cancers (Basel) 2021;13:2900. [PMID: 34200553 DOI: 10.3390/cancers13122900] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Banerjee S. Aldo Keto Reductases AKR1B1 and AKR1B10 in Cancer: Molecular Mechanisms and Signaling Networks. Adv Exp Med Biol 2021. [PMID: 33945128 DOI: 10.1007/5584_2021_634] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Yang S, Zhao Y, Yu J, Fan Z, Gong ST, Tang H, Pan L. Sugar Alcohols of Polyol Pathway Serve as Alarmins to Mediate Local-Systemic Innate Immune Communication in Drosophila. Cell Host Microbe 2019;26:240-251.e8. [PMID: 31350199 DOI: 10.1016/j.chom.2019.07.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
13 Beyoğlu D, Park EJ, Quiñones-Lombraña A, Dave A, Parande F, Pezzuto JM, Idle JR. Addition of grapes to both a standard and a high-fat Western pattern diet modifies hepatic and urinary metabolite profiles in the mouse. Food Funct 2022. [PMID: 35876245 DOI: 10.1039/d2fo00961g] [Reference Citation Analysis]
14 Hou Q, Duan ZJ. Metabonomic window into hepatitis B virus-related hepatic diseases. World J Hepatol 2016; 8(1): 1-8 [PMID: 26783418 DOI: 10.4254/wjh.v8.i1.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
15 Wang M, Keogh A, Treves S, Idle JR, Beyoğlu D. The metabolomic profile of gamma-irradiated human hepatoma and muscle cells reveals metabolic changes consistent with the Warburg effect. PeerJ 2016;4:e1624. [PMID: 26823999 DOI: 10.7717/peerj.1624] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
16 Pabst T, Kortz L, Fiedler GM, Ceglarek U, Idle JR, Beyoğlu D. The plasma lipidome in acute myeloid leukemia at diagnosis in relation to clinical disease features. BBA Clin 2017;7:105-14. [PMID: 28331812 DOI: 10.1016/j.bbacli.2017.03.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
17 Fu X, Guo X, Wu S, Lin Q, Liu L, Liang H, Niu Y, Li N. Non-Targeted UHPLC-Q-TOF/MS-Based Metabolomics Reveals a Metabolic Shift from Glucose to Glutamine in CPB Cells during ISKNV Infection Cycle. Metabolites 2019;9:E174. [PMID: 31487859 DOI: 10.3390/metabo9090174] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
18 Tang J, Xiong K, Zhang T, Han Han. Application of Metabolomics in Diagnosis and Treatment of Chronic Liver Diseases. Crit Rev Anal Chem 2020;:1-11. [PMID: 33146026 DOI: 10.1080/10408347.2020.1842172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Yeh MM, Boukhar S, Roberts B, Dasgupta N, Daoud SS. Genomic variants link to hepatitis C racial disparities. Oncotarget. 2017;8:59455-59475. [PMID: 28938650 DOI: 10.18632/oncotarget.19755] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
20 Meoni G, Lorini S, Monti M, Madia F, Corti G, Luchinat C, Zignego AL, Tenori L, Gragnani L. The metabolic fingerprints of HCV and HBV infections studied by Nuclear Magnetic Resonance Spectroscopy. Sci Rep. 2019;9:4128. [PMID: 30858406 DOI: 10.1038/s41598-019-40028-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
21 Beyoğlu D, Simillion C, Storni F, De Gottardi A, Idle JR. A Metabolomic Analysis of Cirrhotic Ascites. Molecules 2022;27:3935. [PMID: 35745058 DOI: 10.3390/molecules27123935] [Reference Citation Analysis]
22 Liu LL, Lin Y, Zhuang JC, Ren J, Jiang XY, Chen MH, Chen W, Luo X, Yan JH, Niu JJ, Yang TC. Analysis of serum metabolite profiles in syphilis patients by untargeted metabolomics. J Eur Acad Dermatol Venereol 2019;33:1378-85. [PMID: 30803039 DOI: 10.1111/jdv.15530] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
23 Sato S, Genda T, Ichida T, Murata A, Tsuzura H, Narita Y, Kanemitsu Y, Ishikawa S, Kikuchi T, Mori M. Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma. J Gastroenterol Hepatol. 2016;31:1315-1322. [PMID: 26758591 DOI: 10.1111/jgh.13295] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
24 Tounta V, Liu Y, Cheyne A, Larrouy-Maumus G. Metabolomics in infectious diseases and drug discovery. Mol Omics 2021;17:376-93. [PMID: 34125125 DOI: 10.1039/d1mo00017a] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Torres-Mena JE, Salazar-Villegas KN, Sánchez-Rodríguez R, López-Gabiño B, Del Pozo-Yauner L, Arellanes-Robledo J, Villa-Treviño S, Gutiérrez-Nava MA, Pérez-Carreón JI. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC. Dig Dis Sci 2018;63:934-44. [PMID: 29383608 DOI: 10.1007/s10620-018-4943-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
26 Manchester M, Anand A. Metabolomics: Strategies to Define the Role of Metabolism in Virus Infection and Pathogenesis. Adv Virus Res 2017;98:57-81. [PMID: 28433052 DOI: 10.1016/bs.aivir.2017.02.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 5.2] [Reference Citation Analysis]